|
Bailey McCann, Opalesque New York: Healthcare private equity had a robust 2019. Total disclosed deal value reached $78.9 billion, the highest on record, and the deal count of 313 was in line with the 316 deals of 2018, according to new data from Bain and Company.
Healthcare private equity also outperformed all other sectors of private equity activity representing 18% of all disclosed deal value. The most active market was in the US.
Along with deal activity, healthcare exits also posted a banner year. Disclosed deal values rose 29% to $40.8 billion and count rose 13% to 126.
The average deal size rose roughly 25% as funds focused more on larger assets. There were 27 deals greater than $1 billion in value in 2019, compared with 18 such deals in 2018. Biopharma had an exceptional year as disclosed value grew 146% to $40.7 billion. HCIT across sectors also excelled, with value doubling to $17.5 billion.
The increase in deal size represents increased investor confidence in healthcare companies overall. 2019 also saw the largest buyout deal in over a decade with the $10.1 billion acquisition of Nestlé Skin Health by EQT and Abu Dhabi Investment Authority. This deal was especially notable as overall deal size in other sectors has declined as private equity firms face stiffer competition and high valuations.
Looking ahead, Bain & Company expects that deal flow in the healthcare sector will remain strong. Increased worldwide demand for healthcare services was...................... To view our full article Click here
|
RSS
